Outcome of Tandem Autologous/Allogeneic Hematopoietic Cell Transplantation in High-Risk Non Hodgkin's Lymphoma Patients: Stanford University Experience

被引：0
|
作者：
Wudhikarn, Kitsada [1 ]
Lavori, Philip [2 ]
Arai, Sally [1 ]
Johnston, Laura [1 ]
Laport, Ginna G. [1 ]
Lowsky, Robert [1 ]
Miklos, David B. [1 ]
Shizuru, Judith A. [1 ]
Hoppe, Richard T. [3 ]
Benjamin, Jonathan [1 ]
Meyer, Everett [1 ]
Negrin, Robert [1 ]
Weng, Wen-Kai [1 ]
机构：
[1] Stanford Univ, Med Ctr, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2014年 / 20卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2013.12.262
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
235
引用
收藏
页码：S164 / S164
页数：1
相关论文
共 50 条
  • [1] Autologous or allogeneic hematopoietic cell transplantation for non-Hodgkin's lymphoma?
    Blume, KG
    ANNALS OF HEMATOLOGY, 2002, 81 : S9 - S11
  • [2] Feasibility and Efficacy of Tandem Autologous-Allogeneic Transplantation in a Cohort of 111 Patients Affected By High-Risk Hodgkin's and Non-Hodgkin's Lymphoma
    Crocchiolo, R.
    Castagna, L.
    Furst, S.
    El-Cheikh, J.
    Sarina, B.
    Bramanti, S.
    Granata, A.
    Harbi, S.
    Morabito, L.
    Mohty, B.
    Giordano, L.
    Devillier, R.
    Garciaz, S.
    Coso, D.
    Balzarotti, M.
    Chabannon, C.
    Carlo-Stella, C.
    Santoro, A.
    Bouabdallah, R.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S67 - S67
  • [3] Feasibility and Efficacy of Tandem Autologous-Allogeneic Transplantation in a Cohort of 111 Patients Affected By High-Risk Hodgkin's and Non-Hodgkin's Lymphoma
    Crocchiolo, Roberto
    Castagna, Luca
    Fuerst, Sabine
    El Cheikh, Jean
    Sarina, Barbara
    Bramanti, Stefania
    Granata, Angela
    Morabito, Lucio
    Giordano, Laura
    Garciaz, Sylvain
    Coso, Diane
    Bouabdallah, Reda
    Balzarotti, Monica
    Chabannon, Christian
    Carlo-Stella, Carmelo
    Santoro, Armando
    Blaise, Didier
    BLOOD, 2014, 124 (21)
  • [4] Outcome of autologous hematopoietic cell transplantation in high-risk lymphoma patients in first complete remission
    Romejko-Jarosinska, Joanna
    Domanska-Czyz, Katarzyna
    Rymkiewicz, Grzegorz
    Ostrowska, Beata
    Borawska, Anna
    Paszkiewicz-Kozik, Ewa
    Osowiecki, Michal
    Poplawska, Lidia
    Targonski, Lukasz
    Swierkowska-Czeneszew, Monika
    Dabrowska-Iwanicka, Anna
    Grygalewicz, Beata
    Druzd-Sitek, AgnieszKa
    Kotarska, Martyna
    Szymanski, Marcin
    Konecki, Robert
    Walewski, Jan
    BONE MARROW TRANSPLANTATION, 2018, 53 : 613 - 614
  • [5] Tandem Autologous Hematopoietic Progenitor Cell Transplantation (AHPCT) for High-Risk Hodgkin Lymphoma: Mature Results of a Prospective Trial
    Dean, Robert M.
    Kalaycio, Matt
    Pohlman, Brad
    Sobecks, Ronald
    Copelan, Edward A.
    Hill, Brian T.
    Rybicki, Lisa
    Tench, Shawnda
    Bolwell, Brian J.
    BLOOD, 2012, 120 (21)
  • [6] Autologous Transplantation Followed by Reduced-Intensity Allogeneic Transplantation Is Feasible in Patients with High-Risk Non-Hodgkin's Lymphoma
    Crocchiolo, Roberto
    Castagna, Luca
    Furst, Sabine
    El-Cheikh, Jean
    Faucher, Catherine
    Oudin, Claire
    Bouabdallah, Reda
    Coso, Diane
    Florence, Broussais
    Ivanov, Vadim
    Marc, Schiano Jean
    Aurran, Therese
    Chabannon, Christian
    Balzarotti, Monica
    Santoro, Armando
    Blaise, Didier
    BLOOD, 2011, 118 (21) : 1341 - 1342
  • [7] Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma
    Shimoni, A
    Hardan, I
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Ben-Bassat, I
    Nagler, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (03) : 457 - 464
  • [8] Tandem Autologous/Non-Myeloablative Allogeneic Transplantation for High Risk Non-Hodgkin Lymphoma (NHL)
    Fakhri, Bita
    Cashen, Amanda
    Comer, Holly
    Abboud, Camille
    Westervelt, Peter
    DiPersio, John E.
    Stockerl-Goldstein, Keith
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S300 - S300
  • [9] Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma
    Green, Damian J.
    Maloney, David G.
    Storer, Barry E.
    Sandmaier, Brenda M.
    Holmberg, Leona A.
    Becker, Pamela S.
    Fang, Min
    Martin, Paul J.
    Georges, George E.
    Bouvier, Michelle E.
    Storb, Rainer
    Mielcarek, Marco
    BLOOD ADVANCES, 2017, 1 (24) : 2247 - 2256
  • [10] Outcome of relapsed non-Hodgkin's lymphoma patients after allogeneic and autologous transplantation
    Vaishampayan, U
    Karanes, C
    Du, W
    Varterasian, M
    Al-Katib, A
    CANCER INVESTIGATION, 2002, 20 (03) : 303 - 310
12345